107 related articles for article (PubMed ID: 1903438)
1. Dopa and dopamine cause cultured neuronal death in the presence of iron.
Tanaka M; Sotomatsu A; Kanai H; Hirai S
J Neurol Sci; 1991 Feb; 101(2):198-203. PubMed ID: 1903438
[TBL] [Abstract][Full Text] [Related]
2. [Iron-dependent cytotoxic effects of dopa on cultured neurons of the dorsal root ganglia].
Tanaka M; Sotomatsu A; Kanai H; Hirai S
Rinsho Shinkeigaku; 1990 Apr; 30(4):379-83. PubMed ID: 2117513
[TBL] [Abstract][Full Text] [Related]
3. [Oxidative stress and the brain].
Tanaka M
Nihon Ronen Igakkai Zasshi; 1997 Sep; 34(9):706-10. PubMed ID: 9430979
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid peroxidation induced by the catechol-Fe3+(Cu2+) complex: a possible mechanism of nigrostriatal cell damage.
Sotomatsu A; Nakano M; Hirai S
Arch Biochem Biophys; 1990 Dec; 283(2):334-41. PubMed ID: 2125819
[TBL] [Abstract][Full Text] [Related]
5. Dopamine and DOPA cause release of iron from ferritin and lipid peroxidation of liposomes.
Tanaka M; Yoshida T; Okamoto K; Hirai S
Neuroreport; 1999 Jun; 10(9):1883-7. PubMed ID: 10501526
[TBL] [Abstract][Full Text] [Related]
6. Combined histochemical and biochemical demonstration of nigral vulnerability to lipid peroxidation induced by dopa and iron.
Tanaka M; Sotomatsu A; Kanai H; Hirai S
Neurosci Lett; 1992 Jun; 140(1):42-6. PubMed ID: 1407698
[TBL] [Abstract][Full Text] [Related]
7. Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors.
Lai CT; Yu PH
Biochem Pharmacol; 1997 Feb; 53(3):363-72. PubMed ID: 9065740
[TBL] [Abstract][Full Text] [Related]
8. O2- generation and lipid peroxidation during the oxidation of a glycated polypeptide, glycated polylysine, in the presence of iron-ADP.
Sakurai T; Sugioka K; Nakano M
Biochim Biophys Acta; 1990 Mar; 1043(1):27-33. PubMed ID: 2155661
[TBL] [Abstract][Full Text] [Related]
9. Iron accelerates the conversion of dopamine-oxidized intermediates into melanin and provides protection in SH-SY5Y cells.
Izumi Y; Sawada H; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
J Neurosci Res; 2005 Oct; 82(1):126-37. PubMed ID: 16108071
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.
Spencer JP; Jenner A; Butler J; Aruoma OI; Dexter DT; Jenner P; Halliwell B
Free Radic Res; 1996 Feb; 24(2):95-105. PubMed ID: 8845917
[TBL] [Abstract][Full Text] [Related]
11. Lipid peroxidation in brain: interactions of L-DOPA/dopamine with ascorbate and iron.
Li CL; Werner P; Cohen G
Neurodegeneration; 1995 Jun; 4(2):147-53. PubMed ID: 7583678
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
13. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.
Izumi Y; Sawada H; Sakka N; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
J Neurosci Res; 2005 Mar; 79(6):849-60. PubMed ID: 15712215
[TBL] [Abstract][Full Text] [Related]
14. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.
Gai WP; Vickers JC; Blumbergs PC; Blessing WW
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1039-46. PubMed ID: 7916375
[TBL] [Abstract][Full Text] [Related]
15. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
Damier P; Hirsch EC; Agid Y; Graybiel AM
Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen metabolite-induced toxicity to cultured bovine endothelial cells: status of cellular iron in mediating injury.
Hiraishi H; Terano A; Razandi M; Pedram A; Sugimoto T; Harada T; Ivey KJ
J Cell Physiol; 1994 Jul; 160(1):132-4. PubMed ID: 8021293
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of bromocriptine on phospholipid peroxidation induced by dopa and iron.
Tanaka M; Sotomatsu A; Yoshida T; Hirai S
Neurosci Lett; 1995 Jan; 183(1-2):116-9. PubMed ID: 7746468
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
[TBL] [Abstract][Full Text] [Related]
19. Copper neurotoxicity is dependent on dopamine-mediated copper uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line.
Paris I; Dagnino-Subiabre A; Marcelain K; Bennett LB; Caviedes P; Caviedes R; Azar CO; Segura-Aguilar J
J Neurochem; 2001 Apr; 77(2):519-29. PubMed ID: 11299314
[TBL] [Abstract][Full Text] [Related]
20. Clues to the mechanism underlying dopamine cell death in Parkinson's disease.
Jenner P
J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):22-8. PubMed ID: 2666576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
